Showing papers by "Monica Bellei published in 2023"
••
TL;DR: The FIL_ReRi trial as mentioned in this paper investigated the activity and safety of the chemo-free combination of rituximab and lenalidomide (R2) in ≥ 70-year-old untreated frail DLBCL patients.